Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 100
Avg Vol 15,128
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 38%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testin...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 34 935 71 22 00
Fax: 34 938 00 80 00
Address:
Parque Empresarial Can Sant Joan, Avinguda de la Generalitat, 152-158 Sant Cugat del Valles, Barcelona, Spain
Latest News on GIKLY
No data available.